chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pneumonia; Heart attack; Cancer; COPD; Got sick; Headache; This is a spontaneous report from a contactable consumer received via Pfizer sponsored program  support. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 16Mar2021 (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose on 16Mar2021 and she got sick, heart attack, cancer, chronic obstructive pulmonary disease (COPD),  and pneumonia. At the time of report the patient has a headache. The 2nd dose schedule will be on 27Apr2021 and wanted to know if she should go and take the 2nd shot because the doctor's office she went to was unsure if they are open. The outcome of the events was unknown.  Information on the lot/ batch number has been requested
A report has been received from a physician concerning a 10 year old, male patient. No relevant history or concomitant medication was reported. On an unknown date the patient received FLUMIST. On 05-Oct-2013 the patient who received FLUMIST experienced hives and swelling on lips 12 hours later. The patient did not have Egg allergy and the reporter also stated that the patient received FLUMIST before with no problems. At the time of reporting, the event of hives was ongoing. The report was consideer3ed to be non-serious by the reporter.
Immediate deep and intense pain in upper R arm at injection site, then 24 hours later, almost to the minute, spiked a fever to 99.9 deg., chills, felt as if I was coming down with the flu -weak, and  general malaise. That lasted for 18 hours then just significant widespread swelling in my upper arm with a reddened three petaled area - looked like the bio-hazard symbol. One full week later, it still hurts and the bruise from the injection is just yellowing-out, but it is still tender to the touch.
Suspected vaccination failure; Got the vaccine but still got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Got the vaccine but still got shingles). The outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be possibly related to Shingrix.     The company considered the vaccination failure and shingles to be possibly related to Shingrix.   Additional Information: GSK Receipt date: 09-MAY-2023 This case was received from the patient's friend via interactive digital media. The patient developed shingles after the shot. The reporter said the patient wish she had never took and she did not realize how painful they really could be. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Patient received first Flu shot on 9/9/11 along with PEDIARIX, PCV13, Hib and ROTATEQ and had no reactions. His second Flu shot was given 10/24/11 and about 24 hours later he developed hives which lasted for about 24 hours. No intervention was needed. He has since eaten eggs without any reaction.
After administration of VAXNEUVANCE the prefilled syringe broke at the hub when the needle safety was applied.
Patient recieved Trumenba vaccine in the left deltoid. 1-2 minutes after administration, the patient fainted while sitting in the chair and fell onto the floor. Patient immediately came to and moved himself back onto the chair. It was at this time that the medical staff had made it back to the room upon hearing a loud thud from the room a few seconds prior.  The patient stated that he had passed out but that he was fine. After having the patient rest for a few minutes his blood pressure, pulse and O2 was taken. B/P= 112/62, Pulse= 72 & O2= 99. The patient was observed for 20 minutes after the incident before being allowed to leave. Patient again stated that he felt fine and he did not hit his head or injury himself.
Headache, Myalgia, Arthralgia, pain, red site Narrative:
inapproriate schedule of vaccine administration; Shingles; Fever; chills; muscle aches; fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 60-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, dose 1 (Lot Number: er8731 expiry date was not reported) via an unspecified route of administration at arm Left on 16Apr2021 16:00 as a single dose, dose 2 (Lot Number: ew0182 expiry date was not reported) via an unspecified route of administration arm Left on 16Apr2021 (inappropriate schedule of vaccine administration) as a single dose for covid-19 immunization (age at vaccination:60-year-old). Medical history included appendicitis, hysterectomy, gallbladder disorder from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (LEVOXYL), ginkgo biloba (GINKO [GINKGO BILOBA]), magnesium (MAGNESIUM) taken for an unspecified indication, start and stop date were not reported. The patient previously took sulfa [sulphanilamide] and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. on 24May2021 12:00 the patient experienced shingles, fever, chills, muscle aches, fatigue. Therapeutic measures were taken valacyclovir as a result of shingles, fever, chills, muscle aches, fatigue. Outcome of the events was not recovered.   Follow-Up (12Jul2021): Follow-up attempts are completed. No further information is expected.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave 4 doses of expired Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 061B22A) for COVID-19 prophylaxis.  No Medical History information was reported. On 30-Nov-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave 4 doses of expired Moderna Covid-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We gave 4 doses of expired Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (We gave 4 doses of expired Moderna Covid-19 vaccine). Concomitant medication was not reported.The vial was initially stored in the refrigerator on 02-Nov-2022 and patient received monovalent vaccine dose on 30-Nov-2022. The vials were unbroken of size 5.5 ml. The vial did not undergo any temperature excursions. Treatment medication as not reported.
Patient received 2nd dose of Pfizer COVID19 vaccine on 2/10/21.  Patient had 3 household members test COVID positive prior to reporting COVID symptom onset for patient starting 4/27/21.  Patient tested positive for COVID19 via PCR swab on 4/28/21
Information has been received from a pharmacy tech concerning a pt (age and sex not specified) who on 08Oct05 was vaccinated with pneumococcal 23v polysaccharide vaccine (650456/0974P). On 08Oct05, within 24 hrs, the pt developed an injection site reaction of swelling and redness. The pt sought unspecified medical attention. It was reported they have requested a check of medical attention. It was reported, they have requested a check of Lot 650456/0974P. At the time of this report, the outcome of the events were unk. The records of testing prior to release of this lot have been checked by QA and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
Bad Headache/Lesions on the roof of mouth/Red rash upper body and shoulders/
This is a spontaneous report from a contactable physician via a Pfizer sales representative. This physician reported similar events for four patients. This is the third of four patients. A male patient of an unspecified age and ethnicity received a single dose of TRUMENBA via an unspecified route of administration on an unspecified date. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced huge rash probably like a whole foot long (rash), swelling, very red and warm to touch, severe pain at the injection site that went all the way up to the back of their neck and all the way down to their hands. The events were described as pain at the injection site, large redness, and swelling with hotness, radiating pain both to the neck and all the way down to the hands. Therapeutic measures were taken as a result of events and included MOTRIN and BENADRYL. Clinical outcome of the adverse events was unknown at time of this report. Follow-up (29-SEP-2016): Follow-up attempts are completed. No further information is expected.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 23-Jun-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Date of refrigeration is 7 May 2021 No treatment information was provided.
Headache, Myalgia, Arthralgia, Fever, Fever chills body ache fatigue and headache, joint/hip pain Narrative:
Information has been received from a registered nurse concerning a child patient who on approximately 03-AUG-2010 "a month ago" was vaccinated with a dose of VARIVAX (Merck) (Lot# not reported). Subsequently, on an unspecified date, the patient's are was red, swollen and warm at injection site. No lab diagnostics studies were performed. At the time of the report, the patient's outcome was unknown. The patient sought unspecified medical attention. This is one of several reports received from the same source. No further information is available.
Within 1/2 hour of immunization, patient's eyes became red and swollen, trouble breathing and felt poorly. Patient with wheezing on exam; given Benadryl 25mg IM and Albuterol nebulizer. Was given Epi; admitted for observation and did well. Discharge Summary received on 9/12/2003 states allergic reaction.
Information has been received from a physician concerning a patient who was vaccinated with mumps virus vaccine live (Jeryl Lynn). Three years after receiving mumps virus vaccine live (Jeryl Lynn), the patient had "low titers." The outcome was not reported. The patient's twin sibling had a similar experience (WAES#0609USA00430). Additional information has been requested.
This spontaneous report was received from a healthcare worker (certified medical assistant) refers to patients of unknown age and gender. The patients medical history, concurrent conditions and concomitant medications were not specified. On unspecified dates, the patients were vaccinated with improperly stored PNEUMOVAX 23 lot # L014458, expiry date 11-FEB-2017 (dose, strength, route, dose numbers, vaccination site unspecified). The previous temperature excursion was reported at a temperature of 34 degrees F for 15 hours. No adverse effects were reported. Product quality complaint (PQC) was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
10/21/04: Pt reports: began to feel ill, 10/22 by 10PM 101.5 degrees. By midnight 102 T, became diaphoretic, had to change sheets and night gown, 10/23 low grade fever, Tachycardia, right leg was restless, right arm itching but had sot in left arm 10/24 entire body shaking, hoarseness present, low grade temp. 10/25 better 10/26 temp normal. No further problems. She call her doctor on 10/22. He told her he was not fine. had these symptoms did not suggest she see him.
pt states the night after getting the vaccine he developed 103 fever along with chills,  body aches and fatigue.  He tested his coumadin level was doubled read 5.1 and is normally 2.5 to 3.5.  He has had muscle ache and pain in left arm from his elbow to his shoulder. He has been alternating heat and cold packs to help with pain.  He continues to have pain at this time.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Covid-19 vaccine that were given beyond the 30 day use by date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2022 at 1:05 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Feb-2022 at 1:05 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. It was reported that vaccine was administered on 02-Feb-2022 at 13:05:58. Its 30 days expiry date vaccine went into 2 to 8 °C thaw state on or about to 20-Dec-2021, this vaccine administered until its date of 04-Apr-2022. No treatment information provided.   This case was linked to MOD-2022-542869 (Patient Link).
trouble swallowing, breathing, quite faint--similar to anaphylactic shock suffered during chemo treatment
Itchiness in the arm; Arm was red; Arm was hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE PRURITUS (Itchiness in the arm) and VACCINATION SITE ERYTHEMA (Arm was red) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced VACCINATION SITE WARMTH (Arm was hot) and VACCINATION SITE ERYTHEMA (Arm was red). On 06-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness in the arm). At the time of the report, VACCINATION SITE WARMTH (Arm was hot), VACCINATION SITE PRURITUS (Itchiness in the arm) and VACCINATION SITE ERYTHEMA (Arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Company Comment: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Shingles vaccine SHINGRIX. Increasing soreness initially. On the 2nd day, a red strip about 4 inches long going down my arm from the shot. On the 3rd day when I woke up it was triangular in shape and covered 1/3 of my upper arm under the shot site. It was very red and swollen.
On an unspecified date, the pt received his first dose of Lymerix for prevention of Lyme disease. Subsequently, he experienced burning sensation at the injection site and knees, hands and feet.  The most recent information received on 1/11/00, reports the condition of the pt as unknown.
Intense itching at site of vaccination.  Rash at site of vaccination about 2 by 3 inches, very red. Low grade fever slight headache.
mild chill; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (mild chill) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced CHILLS (mild chill). In January 2021, CHILLS (mild chill) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-405969 (Patient Link).
mom of child called on 12AUG93 & states rt arm is reddened, hot & swollen from site to shoulder & dec to elbow; reddness goes almost around arm; pt temp 104.7; pt didn't eat until 3PM;
patient fainted in the office lobby about 10 minutes after receiving the vaccine, she was escorted to an exam room where vitals were recorded and she was given water and crackers.
exp nausea;vomiting;dehydration;fever;clinic 7/2-7/3-admit to ER w/high fever;dehydration;blood tests-elevated liver enzymes; monitored blood tests;rt flank pain;tiny calcified density projected over rt side of bladder;renal stone protocol
Patient received arexvy and prevnar 20. Immediately after getting the prevnar, she stated that her arm felt strange. She had a hard time describing it. We had her sit at the bench to observe. She stated it got better than she felt tingling all over her body. She doesn't think it was bad, but it was concerning to her. Daughter came in from the car to walk her out.  Called pt a few hours later and she stated all the tingling went away and she feels much better. Just some arm soreness from the shots. She mentioned that she had very little to eat in the morning and could contribute to it.
About 4 hours after receiving the vaccine, I felt really tired and got a headache. I went to bed and profusely sweat throughout the night, but my feet were freezing. I woke up the next morning, and all my joints hurt. My knees, elbows, but especially my spine. It hurt to move in bed. I continued to experience the pain and hot flashes. On Sunday I finally felt normal. Everything seemed fine for a while and then in April I had some chest pains. I went to the ER where they saw my troponin levels were elevated. They did a catheter. An MRI showed there was no scarring or signs of damage. I do not have a history of high cholesterol, blood clots, high blood pressure or anything like that. My doctors are struggling to find an answer to this because I have no pre cursors for these conditions. I was not taking any medications; I had no other illnesses. I am a nurse, but I always wear appropriate PPE when dealing with patients. Since then, everything has remained normal to this point. I now take a baby aspirin every day, cholesterol medication and About 4 hours after receiving the vaccine, I felt really tired and got a headache. I went to bed and profusely sweat throughout the night, but my feet were freezing. I woke up the next morning, and all my joints hurt. My knees, elbows, but especially my spine. It hurt to move in bed. I continued to experience the pain and hot flashes. On Sunday I finally felt normal. Everything seemed fine for a while and then in April I had some chest pains. I went to the ER where they saw my troponin levels were elevated. They did a catheter. An MRI showed there was no scarring or signs of damage. I do not have a history of high cholesterol, blood clots, high blood pressure or anything like that. My doctors are struggling to find an answer to this because I have no pre cursors for these conditions. I was not taking any medications; I had no other illnesses. I am a nurse, but I always wear appropriate PPE when dealing with patients. Since then, everything has remained normal to this point. I now take a baby aspirin every day, cholesterol medication and plavix.
Burning sensation, swelling, pain, tingling in hand & fingers, redness around shot site 4"-6" in diameter. Tender/sore to touch.
I had pain in my arm when I received the vaccine. I also had nausea, a headache, joint pain, and body aches the day after and everyday since I received the vaccine. Today I vomited twice due to the headache and nausea.
Narrative:  Patient passed away at home under the care of hospice at approximately 6:15pm on 5/18/22.
Information has been received from a physician concerning an 11 year old female who was the daughter of a nurse that works in his office. On 30-SEP-2006 the patient was vaccinated with a 0.5 ml dose of GARDASIL (lot #654540/0800F). At that same time, the patient received a second dose of FLUMIST. On 01-OCT-2006 the patient had a "funny feeling in her face." By 03-OCT-2006 "her face was crooked on one side and becoming paralyzed." The patient was treated with an unspecified steroid medication and was reported to be "feeling better," but the symptoms were not totally gone. The patient was seen by a neurologist and was diagnosed with Bell's Palsy. The physician reported that one year ago, the patient was given FLUMIST and had no adverse reactions. At the time of this report, the patient was recovering from the events. The physician reported that it was his opinion that "Bells Palsy was caused by FLUMIST and not GARDASIL." Additional information has been requested.
Rash at injection site the showed up 10 days after injection, not getting better and it is spreading.
chills, fever 100.6, headache and chest tightness, denies shortness of breath and cough. Treatment include: Tylenol, patient has history of asthma and report using her inhaler daily.  She denies chest congestion. Outcome: chills, fever resolved,  report residual headache and continued chest tightness recommend to follow-up with primary care doctor- currently working
large local rxn encompassing 1/3 of thigh; hard, red, hot to touch, raised at ctr; adm to hosp for rx of poss cellulitis; disch on 19apr94; thought not to be cellulitis;
Itching, swelling/rash 12-14h after first Pfizer vaccine. Second dose cancelled
patient reported 2/14/23 that they believe high dose caused her to have eye problems (glaucoma).